Biodexa Pharmaceuticals (BDRX) Income from Continuing Operations (2013 - 2026)
Biodexa Pharmaceuticals' Income from Continuing Operations was -$2.35 million in the quarter ended Jun 30, 2026, compared with -$5.3 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Income from Continuing Operations (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biodexa Pharmaceuticals' Income from Continuing Operations was -$17.72 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$8.42 million.
- In earlier years, Income from Continuing Operations was -$7.32 million in the year ended Dec 31, 2024, -$8.81 million in the year ended Dec 31, 2023, -$9.48 million in the year ended Dec 31, 2022 and -$7.51 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Income from Continuing Operations in data going back to the quarter ended Dec 31, 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Biodexa Pharmaceuticals | 41.69 Mn | 18.48 Mn | - | -2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.35 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Jun 30, 2025 | -5.30 Mn |
| Dec 31, 2024 | -4.57 Mn |
| Jun 30, 2023 | -4.83 Mn |
| Dec 31, 2022 | -4.38 Mn |
| Dec 31, 2021 | -7.36 Mn |
| Dec 31, 2020 | -29.30 Mn |
| Dec 31, 2019 | -11.75 Mn |
| Dec 31, 2018 | -13.34 Mn |
| Dec 31, 2017 | -5.79 Mn |
| Dec 31, 2016 | -12.89 Mn |
| Dec 31, 2015 | -26.30 Mn |
| Dec 31, 2014 | -15.59 Mn |
| Dec 31, 2013 | -7.91 Mn |
API Access
Biodexa Pharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();